Akpentolate en es it fr

Akpentolate Brand names, Akpentolate Analogs

Akpentolate Brand Names Mixture

  • No information avaliable

Akpentolate Chemical_Formula


Akpentolate RX_link

No information avaliable

Akpentolate fda sheet

Akpentolate msds (material safety sheet)

Akpentolate MSDS

Akpentolate Synthesis Reference

No information avaliable

Akpentolate Molecular Weight

291.385 g/mol

Akpentolate Melting Point

139 oC (hydrochloride salt)

Akpentolate H2O Solubility

No information avaliable

Akpentolate State


Akpentolate LogP


Akpentolate Dosage Forms

Ophthalmic solution (eye drops)

Akpentolate Indication

Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.

Akpentolate Pharmacology

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

Akpentolate Absorption

Absorbed following ophthalmic administration.

Akpentolate side effects and Toxicity

Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.

Akpentolate Patient Information

No information avaliable

Akpentolate Organisms Affected

Humans and other mammals